The Epidemiology and Prevention of Donor-Derived Infections

Advances in Chronic Kidney Disease

Volumn 16, Issue 4, 2009, Pages 234-241

  Ison, Michael G ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNITED NETWORK FOR ORGAN SHARING   (United States)

Author keywords

Donor derived; Donor screening; Infection; Patient safety; Transplantation

Indexed keywords

ARTICLE; CYTOMEGALOVIRUS; DIAGNOSTIC ACCURACY; DISEASE TRANSMISSION; DONOR DERIVED INFECTION; DONOR SELECTION; EPSTEIN BARR VIRUS; GRAFT INFECTION; GRAFT RECIPIENT; HEALTH CARE POLICY; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MORBIDITY; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; ORGAN DONOR; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RABIES VIRUS; WEST NILE FLAVIVIRUS;

HUMANS; INFECTION; INFECTION CONTROL; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; TISSUE DONORS; UNITED STATES;

EID: 67649354062     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2009.05.002     Document Type: Article

References (39)

1. Ahn J., and Cohen S.M. Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation. Liver Transpl 14 (2008) 1603-1608
2. Bowen PA, 2nd, Lobel SA, Caruana RJ, et al: Transmission of human immunodeficiency virus (HIV) by transplantation: Clinical aspects and time course analysis of viral antigenemia and antibody production. Ann Intern Med 108:46-48, 2988.
3. Calabrese F., Angelini A., Cecchetto A., et al. HIV infection in the first heart transplantation in Italy: fatal outcome. Case report. APMIS 106 (1998) 470-474
4. Fischer S.A., Graham M.B., Kuehnert M.J., et al. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 354 (2006) 2235-2249
5. Iwamoto M., Jernigan D.B., Guasch A., et al. Transmission of West Nile Virus from an organ donor to four transplant recipients. N Engl J Med 348 (2003) 2196-2203
6. Limaye A.P., Connolly P.A., Sagar M., et al. Transmission of histoplasma capsulatum by organ transplantation. N Engl J Med 343 (2000) 1163-1166
7. Lumbreras C., Sanz F., Gonzalez A., et al. Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients. Clin Infect Dis 33 (2001) 722-726
8. Palacios G., Druce J., Du L., et al. A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med 358 (2008) 991-998
9. Srinivasan A., Burton E.C., Kuehnert M.J., et al. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 352 (2005) 1103-1111
10. Avery R.K. Recipient screening prior to solid-organ transplantation. Clin Infect Dis 35 (2002) 1513-1519
11. Screening of donor and recipient prior to solid organ transplantation. Am J Transplant 4 (2004) 10-20 (suppl 10)
12. Ali M.K., Light J.A., Barhyte D.Y., et al. Donor hepatitis C virus status does not adversely affect short-term outcomes in HCV+ recipients in renal transplantation. Transplantation 66 (1998) 1694-1697
13. Gasink L.B., Blumberg E.A., Localio A.R., et al. Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients. JAMA 296 (2006) 1843-1850
14. Chung R.T., Feng S., and Delmonico F.L. Approach to the management of allograft recipients following the detection of hepatitis B virus in the prospective organ donor. Am J Transplant 1 (2001) 185-191
15. de Villa V.H., Chen Y.S., and Chen C.L. Hepatitis B core antibody-positive grafts: recipient's risk. Transplantation 75 (2003) S49-S53
16. Hodson E.M., Craig J.C., Strippoli G.F., et al. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev CD003774(2) (2008)
17. Sun H.Y., Wagener M.M., and Singh N. Prevention of posttransplant cytomegalovirus disease and related outcomes with valganciclovir: A systematic review. Am J Transplant 8 (2008) 2111-2118
18. Souza F.F., Castro E.S.O., Marin Neto J.A., et al. Acute chagasic myocardiopathy after orthotopic liver transplantation with donor and recipient serologically negative for Trypanosoma cruzi: A case report. Transplant Proc 40 (2008) 875-878
19. Chagas disease after organ transplantation-Los Angeles, California, 2006. MMWR Morb Mortal Wkly Rep 55 (2006) 798-800
20. Chagas disease after organ transplantation-United States, 2001. MMWR Morb Mortal Wkly Rep 51 (2002) 210-212
21. Transplantation-transmitted tuberculosis-Oklahoma and Texas, 2007. MMWR Morb Mortal Wkly Rep 57 (2008) 333-336
22. Graham J.C., Kearns A.M., Magee J.G., et al. Tuberculosis transmitted through transplantation. J Infect 43 (2001) 251-254
23. Peters T.G., Reiter C.G., and Boswell R.L. Transmission of tuberculosis by kidney transplantation. Transplantation 38 (1984) 514-516
24. Winthrop K.L., Kubak B.M., Pegues D.A., et al. Transmission of mycobacterium tuberculosis via lung transplantation. Am J Transplant 4 (2004) 1529-1533
25. West Nile virus infections in organ transplant recipients-New York and Pennsylvania, August-September, 2005. MMWR Morb Mortal Wkly Rep 54 (2005) 1021-1023
26. The National Organ Transplant Act. 42 U.S.C. §273 et seq. (1987)
27. The OPTN Final Rule. 42 CFR, part 121 et seq.
28. OPTN Policy 2.2. Available at: http://www.unos.org/PoliciesandBylaws2/policies/pdfs/policy_2.pdf. Accessed May 25, 2009
29. OPTN Policy 4. Available at: http://www.unos.org/PoliciesandBylaws2/policies/pdfs/policy_16.pdf. Accessed May 25, 2009
30. Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. MMWR Morb Mortal Wkly Rep 43 (1994) 1-17
31. Conditions for Coverage and Conditions for Participations: Organ Procurement Organizations. Centers for Medicare and Medicaid Studies. 2 CFR Parts §§486.301-348. Available at: http://www.cms.hhs.gov/CFCsAndCoPs/08_OPOs.asp#TopOfPage. Accessed May 25, 2009
32. Conditions for Coverage and Conditions for Participations: Transplant Center. Centers for Medicare and Medicaid Studies. 42 FR §482.68-§482.104. Available at: http://www.cms.hhs.gov/CFCsAndCoPs/11_transplantcenter.asp#TopOfPage. Accessed May 25, 2009
33. Lumbreras C: Bacterial pathogens and donor transmission. 3rd International Transplant Infectious Diseases Conference. Prague, Czech Republic, September 29-30, 2007
34. Kiberd B.A., and Forward K. Screening for West Nile Virus in organ transplantation: a medical decision analysis. Am J Transplant 4 (2004) 1296-1301
35. Dodd R.Y., Notari E.P., and Stramer S.L. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 42 (2002) 975-979
36. Human immunodeficiency virus infection transmitted from an organ donor screened for HIV antibody-North Carolina. MMWR Morb Mortal Wkly Rep 36 (1987) 306-308
37. Kucirka L.M., Alexander C., Namuyinga R., et al. Viral nucleic acid testing (NAT) and OPO-level disposition of high-risk donor organs. Am J Transplant 9 (2009) 620-628
38. Kucirka L.M., Namuyinga R., Hanrahan C., et al. Formal policies and special informed consent are associated with higher provider utilization of CDC high-risk donor organs. Am J Transplant 9 (2009) 629-635
39. Fishman JA, Strong DM, Kuehnert MJ: Organ and tissue safety workshop 2007: advances and challenges. Cell Tissue Bank, November 19, 2008